Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
budenid steri-nebs 0.5mg/2ml suspension zur inhalation
teva pharma ag - budesonidum - suspension zur inhalation - budesonidum 0.25 mg, polysorbatum 80, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, dinatrii edetas, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - antiasthmatikum - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
budenid steri-nebs 1mg/2ml suspension zur inhalation
teva pharma ag - budesonidum - suspension zur inhalation - budesonidum 0.5 mg, polysorbatum 80, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, dinatrii edetas, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - antiasthmatikum - synthetika
Itálie -
italština -
AIFA (Agenzia Italiana del Farmaco)
desonax polvxinal 120cps200mcg
biofutura pharma spa - budesonide - polvere per inalazione - 200 mcg 120 capsule polvere per inalazione in blister con inalatore
Itálie -
italština -
AIFA (Agenzia Italiana del Farmaco)
desonax polvxinal 60cps 400mcg
biofutura pharma spa - budesonide - polvere per inalazione - 400 mcg 60 capsule polvere per inalazione in blister con inalatore
Itálie -
italština -
AIFA (Agenzia Italiana del Farmaco)
sinesticmite
astrazeneca s.p.a. - formoterolo e budesonide - formoterolo e budesonide
Itálie -
italština -
AIFA (Agenzia Italiana del Farmaco)
symbicort
bb farma s.r.l. - formoterolo e budesonide - formoterolo e budesonide
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
trixeo aerosphere 5/7.2/160 μg druckgasinhalation, suspension
astrazeneca ag - budesonidum, glycopyrronium, formoteroli fumaras dihydricus - druckgasinhalation, suspension - budesonidum 160 µg, glycopyrronii bromidum 9 µg corresp. glycopyrronium 7.2 µg, formoteroli fumaras dihydricus 5 µg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, calcii chloridum dihydricum, norfluranum, ad suspensionem pro dosi. - bpco - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 1 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 1 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
jorveza 0.5 mg compresse orodispersibili
dr. falk pharma ag - budesonidum - compresse orodispersibili - budesonidum 0.5 mg, dinatrii citras sesquihydricus, natrii dihydrogenocitras anhydricus, natrii hydrogenocarbonas, sucralosum, povidonum k 25, natrii docusas, mannitolum, macrogolum 6000, magnesii stearas pro compresso corresp. natrium 25.62 mg. - bei erwachsenen zur behandlung der eosinophilen Ösophagitis (eoÖ) - synthetika
Švýcarsko -
italština -
Swissmedic (Swiss Agency for Therapeutic Products)
budenofalk 3 mg capsule
dr. falk pharma ag - budesonidum - capsule - budesonidum 3 mg, sacchari sphaerae corresp. saccharum 276 mg et maydis amylum, lactosum monohydricum 12 mg, povidonum k 25, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum b, ammonio methacrylatis copolymerum a, triethylis citras, talcum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 127, e 172 (nigrum), natrii laurilsulfas corresp. natrium 0.006 mg, pro capsula. - morbus chron, kollagene colitis - synthetika